POSTN exon 17 antibodies significantly inhibited primary tumor growth in a dose-dependent manner (p < 0.05) (Figure 6A,B), as well as lung metastasis (p < 0.05) (Figure 6C,D). Here, POSTN is linked to neoplasm.